Clinical trial · Interventional
Prevalence of Sleep Disordered Breathing in a Lung Cancer Screening Cohort
Prevalence of Sleep Apnea in a Lung Cancer Screening Cohort Meeting NLST Criteria
NCT02687997CI-TRIAL-00029479SAILScompletedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Prospective study of sleep disordered breathing in a lung cancer screening cohort.
Conditions
Conditions (4)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| COPD | — | UNRESOLVED | — |
| Emphysema | — | UNRESOLVED | — |
| Lung Cancer | Malignant Lung Neoplasm | CURATED_EXACT | 0.92 |
| Sleep Apnea Hypopnea Syndrome | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| poligraphy | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Diagnostic
- description
- Patients enrolled in lung cancer screening subjected to a sleep study.
- interventionNames
- Other: poligraphy
- type
- NO_INTERVENTION
- label
- Contro
- description
- Patients enrolled in lung cancer screening not included in the diagnostic intervention arm
Primary outcomes (1)
- measure
- Prevalence of sleep apnea
- timeFrame
- 1 year
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 55 Years
- Maximum age
- 75 Years
Show eligibility criteria text
Inclusion Criteria: * Age 55-75. * \> 30 pack years tobacco exposure. * Enrolled in lung cancer screening program. Exclusion Criteria: * Inability or unwillingness to undergo a home sleep study.
References
Publications (0)
Data not yet available
No reference posted for this study.